The Claim
In obese men with hypogonadism receiving GLP-1/GIP therapy, a high-protein nutrition intervention at 2.2 g/kg fat-free mass per day reduces lean mass loss to 32% of total weight loss, compared to other nutritional or multimodal interventions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese men with low testosterone on GLP-1/GIP therapy, consuming 2.2 grams of protein per kilogram of fat-free mass daily results in lean mass loss accounting for 32% of total weight loss.
See the scientific wording
In obese men with hypogonadism on GLP-1/GIP therapy, high-protein nutrition alone (2.2 g/kg fat-free mass/day) reduces lean mass loss to 32% of total weight loss, offering partial but insufficient protection compared to multimodal interventions.
When a person eats a lot of protein, the amino acid leucine triggers a cellular switch that tells muscle cells to keep building new proteins, even when the body is breaking down tissue due to weight-loss drugs. This switch keeps muscle loss from getting worse, but it doesn't fully stop it unless other signals like testosterone and muscle use are also present.
What the research says
1 studyFor obese men with low testosterone on weight-loss drugs, eating a lot of protein helps save muscle, but not as much as adding testosterone and lifting weights. The study found that with protein alone, 32% of weight lost was muscle — better than nothing, but not as good as the combo treatment.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.